Clinical Trial Update: Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial investigating SHR-A1921 combined with Adebrelimab and SHR-8068, with or without carboplatin, for advanced non-small cell lung cancer has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• CARBOPLATIN (Carboplatin)
• SHR-8068
• SHR-A1921

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: WITHDRAWN